Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Aarti Drugs Ltd.
Swot
Aarti Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Aarti Drugs Ltd. has 21 Strengths, 6 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(21)
Weakness
(6)
Opportunity
(3)
Threats
(1)
Others
(4)
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Companies with high TTM EPS Growth
Higher DVM Stocks Among Midcaps and Largecaps
PEG lower than Industry PEG
Stocks gaining versus previous close, open price and RSI
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
High Volume, High Gain
Top Gainers
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Decline in Quarterly Net Profit (YoY)
Declining Net Cash Flow : Companies not able to generate net cash
Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
MFs increased their shareholding last quarter
Red Flag: Companies seeing significant coronavirus impact
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
Decline in Net Profit with falling Profit Margin (QoQ)
